[1]
BASHA S, S. and P, S. 2017. DEVELOPMENT AND VALIDATION OF DAPAGLIFLOZIN BY REVERSED-PHASE HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY METHOD AND IT’S FORCED DEGRADATION STUDIES. Asian Journal of Pharmaceutical and Clinical Research. 10, 11 (Nov. 2017), 101–105. DOI:https://doi.org/10.22159/ajpcr.2017.v10i11.19705.